Search for other papers by Sezer Okay in
Current site
Google Scholar
PubMed
Search for other papers by Rukiye Çetin in
Current site
Google Scholar
PubMed
Search for other papers by Fatih Karabulut in
Current site
Google Scholar
PubMed
Search for other papers by Cennet Doğan in
Current site
Google Scholar
PubMed
Search for other papers by Süheyla Sürücüoğlu in
Current site
Google Scholar
PubMed
Search for other papers by Aslıhan Kurt Kızıldoğan in
Current site
Google Scholar
PubMed
Immunogenic potency of the recombinant Erp, HspR, LppX, MmaA4, and OmpA proteins from Mycobacterium tuberculosis (MTB), formulated with Montanide ISA 720 VG adjuvant, was evaluated in BALB/c mice for the first time in this study. The five vaccine formulations, adjuvant, and BCG vaccine were subcutaneously injected into mice, and the sera were collected at days 0, 15, 30, 41, and 66. The humoral and cellular immune responses against vaccine formulations were determined by measuring serum IgG and serum interferon-gamma (IFN-γ) and interleukin-12 (IL-12) levels, respectively. All formulations significantly increased IgG levels post-vaccination. The highest increase in IFN-γ level was provided by MmaA4 formulation. The Erp, HspR, and LppX formulations were as effective as BCG in enhancement of IFN-γ level. The most efficient vaccine boosting the IL-12 level was HspR formulation, especially at day 66. Erp formulation also increased the IL-12 level more than BCG at days 15 and 30. The IL-12 level boosted by MmaA4 formulation was found to be similar to that by BCG. OmpA formulation was inefficient in enhancement of cellular immune responses. This study showed that MmaA4, HspR, and Erp proteins from MTB are successful in eliciting both humoral and cellular immune responses in mice.
Supplementary Materials
- Supplementary Material
-
1.
Cole, S. T. , Brosch, R. , Parkhill, J. , Garnier, T. , Churcher, C. , Harris, D. , Gordon, S. V. , Eiglmeier, K. , Gas, S. , Barry, C. E., 3rd , Tekaia, F. , Badcock, K. , Basham, D. , Brown, D. , Chillingworth, T. , Connor, R. , Davies, R. , Devlin, K. , Feltwell, T. , Gentles, S. , Hamlin, N. , Holroyd, S. , Hornsby, T. , Jagels, K. , Krogh, A. , McLean, J. , Moule, S. , Murphy, L. , Oliver, K. , Osborne, J. , Quail, M. A. , Rajandream, M. A. , Rogers, J. , Rutter, S. , Seeger, K. , Skelton, J. , Squares, R. , Squares, S. , Sulston, J. E. , Taylor, K. , Whitehead, S. , Barrell, B. G. : Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).
-
2.
World Health Organization [WHO]: Global Tuberculosis Report 2017. Accessed on September 18, 2018, from http://www.who.int/entity/tb/publications/global_report/MainText_13Nov2017.pdf?ua=1
-
3.
Agger, E. M. , Andersen, P. : Tuberculosis subunit vaccine development: On the role of interferon-γ. Vaccine 19, 2298–2302 (2001).
-
4.
Pathan, A. A. , Sander, C. R. , Fletcher, H. A. , Poulton, I. , Alder, N. C. , Beveridge, N. E. , Whelan, K. T. , Hill, A. V. , McShane, H. : Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trials. PLoS One 2, e1052 (2007).
-
5.
Horwitz, M. A. , Harth, G. : A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71, 1672 (2003).
-
6.
Pym, A. S. , Brodin, P. , Majlessi, L. , Brosch, R. , Demangel, C. , Williams, A. , Griffiths, K. E. , Marchal, G. , Leclerc, C. , Cole, S. T. : Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9, 533–539 (2003).
-
7.
Zhao, S. , Zhao, Y. , Mao, F. , Zhang, C. , Bai, B. , Zhang, H. , Shi, C. , Xu, Z. : Protective and therapeutic efficacy of Mycobacterium smegmatis expressing HBHA-hIL12 fusion protein against Mycobacterium tuberculosis in mice. PLoS One 7, e31908 (2012).
-
8.
Sibley, L. , Reljic, R. , Radford, D. S. , Huang, J. M. , Hong, H. A. , Cranenburgh, R. M. , Cutting, S. M. : Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model. FEMS Microbiol Lett 358, 170–179 (2014).
-
9.
Liu, W. , Li, J. , Niu, H. , Lin, X. , Li, R. , Wang, Y. , Xin, Q. , Yu, H. , Wu, Y. , Zhu, B. , Tan, J. : Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice. Int Immunopharmacol 53, 83–89 (2017).
-
10.
Smith, I. : Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16, 463 (2003).
-
11.
Sulzenbacher, G. , Canaan, S. , Bordat, Y. , Neyrolles, O. , Stadthagen, G. , Roig-Zamboni, V. , Rauzier, J. , Maurin, D. , Laval, F. , Daffé, M. , Cambillau, C. , Gicquel, B. , Bourne, Y. , Jackson, M. : LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J 25, 1436–1444 (2006).
-
12.
Junqueira-Kipnis, A. P. , Marques Neto, L. M. , Kipnis, A. : Role of fused Mycobacterium tuberculosis immunogens and adjuvants in modern tuberculosis vaccines. Front Immunol 5, 188 (2014).
-
13.
Kang, H. , Yuan, Q. , Ma, H. , Hu, Z. D. , Han, D. P. , Wu, K. , Lowrie, D. B. , Fan, X. Y. : Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic IL-2-producing CD4 T cell frequency post-vaccination. Immunology 143, 661–669 (2014).
-
14.
Osorio, Y. , Cohen, J. , Ghiasi, H. : Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest Ophthalmol Vis Sci 45, 506–514 (2004).
-
15.
Okay, S. , Özcengiz, E. , Gürsel, I. , Özcengiz, G. : Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice. Res Vet Sci 93, 1261–1265 (2012).
-
16.
Laemmli, U. K. : Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685 (1970).
-
17.
Bradford, M. M. : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254 (1976).
-
18.
Scalzo, A. A. , Elliott, S. L. , Cox, J. , Gardner, J. , Moss, D. J. , Suhrbier, A. : Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J Virol 69, 1306–1309 (1995).
-
19.
Mutiso, J. M. , Macharia, J. C. , Taracha, E. , Gicheru, M. M. : Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops). J Biomed Res 26, 8–16 (2012).
-
20.
Towbin, H. , Staehelin, T. , Gordon, J. : Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A 76, 4350–4354 (1979).
-
21.
Dai, G. , Rady, H. F. , Huang, W. , Shellito, J. E. , Mason, C. , Ramsay, A. J. : Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Vaccine 34, 6267–6275 (2016).
-
22.
Liang, Y. , Zhang, X. , Bai, X. , Xiao, L. , Wang, X. , Zhang, J. , Yang, Y. , Song, J. , Wang, L. , Wu, X. : Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice. BMC Immunol 18, 11 (2017).
-
23.
Delogu, G. , Brennan, M. J. : Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun 69, 5606–5611 (2001).
-
24.
Yoshida, S. , Tanaka, T. , Kita, Y. , Kuwayama, S. , Kanamaru, N. , Muraki, Y. , Hashimoto, S. , Inoue, Y. , Sakatani, M. , Kobayashi, E. , Kaneda, Y. , Okada, M. : DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 24, 1191–1204 (2006).
-
25.
Liang, Y. , Wu, X. , Zhang, J. , Xiao, L. , Yang, Y. , Bai, X. , Yu, Q. , Li, Z. , Bi, L. , Li, N. , Wu, X. : Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 66, 419–426 (2012).
-
26.
Zhang, M. , Dong, C. , Xiong, S. : Vesicular stomatitis virus-vectored multi-antigen tuberculosis vaccine limits bacterial proliferation in mice following a single intranasal dose. Front Cell Infect Microbiol 7, 34 (2017).
-
27.
Nyendak, M. , Swarbrick, G. M. , Duncan, A. , Cansler, M. , Huff, E. W. , Hokey, D. , Evans, T. , Barker, L. , Blatner, G. , Sadoff, J. , Douoguih, M. , Pau, M. G. , Lewinsohn, D. A. , Lewinsohn, D. M. : Adenovirally-induced polyfunctional T cells do not necessarily recognize the infected target: Lessons from a phase I trial of the AERAS-402 vaccine. Sci Rep 6, 36355 (2016).
-
28.
Li, W. , Deng, G. , Li, M. , Zeng, J. , Zhao, L. , Liu, X. , Wang, Y. : A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. Mol Immunol 62, 86–95 (2014).
-
29.
Kwon, K. W. , Kim, W. S. , Kim, H. , Han, S. J. , Hahn, M. Y. , Lee, J. S. , Nam, K. T. , Cho, S. N. , Shin, S. J. : Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hypervirulent Mycobacterium tuberculosis strain K. Sci Rep 7, 44151 (2017).
-
30.
Larrouy-Maumus, G. , Layre, E. , Clark, S. , Prandi, J. , Rayner, E. , Lepore, M. , de Libero, G. , Williams, A. , Puzo, G. , Gilleron, M. : Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine 35, 1395–1402 (2017).
-
31.
Xue, Y. , Bai, Y. , Gao, X. , Jiang, H. , Wang, L. , Gao, H. , Xu, Z. : Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein. J Biomed Res 26, 17–23 (2012).
-
32.
Kocíncová, D. , Sondén, B. , de Mendonça-Lima, L. , Gicquel, B. , Reyrat, J. M. : The Erp protein is anchored at the surface by a carboxy-terminal hydrophobic domain and is important for cell-wall structure in Mycobacterium smegmatis. FEMS Microbiol Lett 231, 191–196 (2004).
-
33.
Berthet, F. X. , Lagranderie, M. , Gounon, P. , Laurent-Winter, C. , Ensergueix, D. , Chavarot, P. , Thouron, F. , Maranghi, E. , Pelicic, V. , Portnoï, D. , Marchal, G. , Gicquel, B. : Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282, 759–762 (1998).
-
34.
de Mendonça-Lima, L. , Bordat, Y. , Pivert, E. , Recchi, C. , Neyrolles, O. , Maitournam, A. , Gicquel, B. , Reyrat, J. M. : The allele encoding the mycobacterial Erp protein affects lung disease in mice. Cell Microbiol 5, 65–73 (2003).
-
35.
Martinez, V. , Carcelain, G. , Badell, E. , Jouan, M. , Mauger, I. , Sellier, P. , Truffot, C. , Bricaire, F. , Arend, S. M. , Ottenhoff, T. , Autran, B. , Gicquel, B. : T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals. BMC Infect Dis 7, 83 (2007).
-
36.
Yang, Y. , Auguin, D. , Delbecq, S. , Dumas, E. , Molle, G. , Molle, V. , Roumestand, C. , Saint, N. : Structure of the Mycobacterium tuberculosis OmpATb protein: A model of an oligomeric channel in the mycobacterial cell wall. Proteins 79, 645–661 (2011).
-
37.
Dao, D. N. , Sweeney, K. , Hsu, T. , Gurcha, S. S. , Nascimento, I. P. , Roshevsky, D. , Besra, G. S. , Chan, J. , Porcelli, S. A. , Jacobs, W. R. : Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4, e1000081 (2008).
-
38.
Derrick, S. C. , Dao, D. , Yang, A. , Kolibab, K. , Jacobs, W. R. , Morris, S. L. : Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis. PLoS One 7, e32959 (2012).
-
39.
Bell, C. , Smith, G. T. , Sweredoski, M. J. , Hess, S. : Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: A comprehensive resource for tuberculosis research. J Proteome Res 11, 119–130 (2012).
-
40.
Stewart, G. R. , Snewin, V. A. , Walzl, G. , Hussell, T. , Tormay, P. , O’Gaora, P. , Goyal, M. , Betts, J. , Brown, I. N. , Young, D. B. : Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7, 732–737 (2001).
-
41.
Lefèvre, P. , Denis, O. , De Wit, L. , Tanghe, A. , Vandenbussche, P. , Content, J. , Huygen, K. : Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis. Infect Immun 68, 1040–1047 (2000).
-
42.
Prados-Rosales, R. , Carreño, L. , Cheng, T. , Blanc, C. , Weinrick, B. , Malek, A. , Lowary, T. L. , Baena, A. , Joe, M. , Bai, Y. , Kalscheuer, R. , Batista-Gonzalez, A. , Saavedra, N. A. , Sampedro, L. , Tomás, J. , Anguita, J. , Hung, S. C. , Tripathi, A. , Xu, J. , Glatman-Freedman, A. , Jacobs, W. R., Jr. , Chan, J. , Porcelli, S. A. , Achkar, J. M. , Casadevall, A. : Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog 13, e1006250 (2017).
Please, download the file from HERE
Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary
Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- Chemical Abstracts
- Global Health
- Index Medicus
- Index Veterinarius
- Medline
- Referativnyi Zhurnal
- SCOPUS
- Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 1.3 |
| Rank by Impact Factor | Q4 (Immunology) |
| Journal Citation Indicator | 0.31 |
| Scopus | |
| CiteScore | 2.3 |
| CiteScore rank | Q3 (Infectious Diseases) |
| SNIP | 0.389 |
| Scimago | |
| SJR index | 0.308 |
| SJR Q rank | Q3 |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article (only for OA publications) |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 772 EUR / 848 USD Print + online subscription: 860 EUR / 944 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
1954 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1217-8950 (Print) |
| ISSN | 1588-2640 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Mar 2024 | 19 | 0 | 0 |
| Apr 2024 | 67 | 0 | 0 |
| May 2024 | 44 | 0 | 0 |
| Jun 2024 | 43 | 0 | 1 |
| Jul 2024 | 40 | 0 | 0 |
| Aug 2024 | 19 | 0 | 0 |
| Sep 2024 | 43 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.